A 73-year-old white gentleman with a medical history significant for stage IIA (pT3a,
N0, M0) malignant melanoma managed by wide local excision from his right shoulder
was referred to our cutaneous clinic for evaluation of locally recurrent disease.
An excisional biopsy of the lesion 3 months prior had been interpreted as consistent
with malignant melanoma, spindle cell type, with an invasive component and positive
margins. Immunohistochemical staining was negative for pankeratin, desmin, HMB 45,
and Melan A, yet positive for S100, supporting the assigned diagnosis. Positron emission
tomography/computed tomography imaging ordered for staging reported no evidence of
focal hypermetabolic activity but did note splenomegaly and diffuse enhancement throughout
the skeletal system consistent with marrow stimulation. During his follow-up appointment
to review the imaging, his examination revealed an interval appearance of multiple
painless, nonpruritic erythematous nodules on the torso and arms. He denied any associated
constitutional symptoms (eg, fevers, night sweats, unintended weight loss, excessive
fatigue). Three years prior to presentation, he had undergone an extensive workup
for thrombocytopenia and leukocytosis. This included a bone marrow biopsy that was
negative for malignancy or myelodysplastic syndrome. The patient was otherwise healthy
and active.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Myeloid sarcoma: Current approach and therapeutic options.Ther Adv Hematol. 2011; 2: 309-316
- How I treat extramedullary acute myeloid leukemia.Blood. 2011; 118: 3785-3793
- Myeloid sarcoma: clinicopathologic, phenotypic and cytogenetic analysis of 92 adult patients.Leukemia. 2007; 21: 340-350
- Granulocytic sarcoma in nonleukemic patients.Cancer. 1986; 58: 2697-2709
- Extramedullary myeloid cell tumors in acute non- lymphocytic leukemia: a clinical review.J Clin Oncol. 1995; 13: 1800-1816
- Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas.Leukemia. 2007; 21: 1566-1570
- FLT3 mutations in myeloid sarcoma.Br J Haematol. 2004; 126: 785-791
- Granulocytic sarcoma: 32 cases and review of the literature.Leuk Lymphoma. 2006; 47: 2527-2541
- Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey.Leuk Res. 2017; 53: 74-81
Article info
Publication history
Published online: May 02, 2018
Accepted:
April 2,
2018
Received in revised form:
April 1,
2018
Received:
March 4,
2018
Uma Paniker, MD, Section EditorFootnotes
Funding: None.
Conflicts of Interest: None.
Authorship: All authors had access and a role in writing the manuscript.
Identification
Copyright
© 2018 Elsevier Inc. All rights reserved.